What's new? Log in Free sign up

Soliton (SOLY)

Company Profile

Company profile

Ticker

SOLY

Exchange

Website

www.soliton.com

CEO

Bradley A. Hauser

Incorporated

Location

Fiscal year end

Industry (SIC)

Surgical & Medical Instruments & Apparatus

3M • Ares Capital • Stryker • Boston Scientific • Solventum • Becton, Dickinson and • Baxter International • Teleflex • Hercules Capital • ResMed ...

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

IRS number

364729076

SOLY stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Securities registration termination

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Registration of securities for employees (post-effective amendment)

Registration of securities for employees (post-effective amendment)

Registration of securities for employees (post-effective amendment)

Prospectus update (post-effective amendment)

Prospectus update (post-effective amendment)

Prospectus update (post-effective amendment)

Transcripts

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

Remeditex Ventures LLC

Change in insider ownership

Michael S. Kaminer

Niquette L. Hunt

Danika R Harrison

Jonathan P. Foster

Christopher Capelli

Financial summary

Financial statements Chart SOLY financial data

Quarter (USD)	Sep 21	Jun 21	Mar 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	21.95 mm	21.95 mm	21.95 mm	21.95 mm	21.95 mm	21.95 mm
Cash burn (monthly)	(no burn)	1.07 mm	2.10 mm	2.00 mm	1.49 mm	1.42 mm
Cash used (since last report)	n/a	42.96 mm	83.97 mm	80.23 mm	59.72 mm	56.94 mm
Cash remaining	n/a	-21.01 mm	-62.02 mm	-58.28 mm	-37.78 mm	-34.99 mm
Runway (months of cash)	n/a	-19.6	-29.6	-29.1	-25.3	-24.6

Beta Read what these cash burn values mean

Financial data from Soliton earnings reports.

Institutional ownership, Q4 2021

SOLY institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	1	76	-98.7%
Opened positions	1	21	-95.2%
Closed positions	76	20	+280.0%
Increased positions	0	30	EXIT
Reduced positions	0	11	EXIT

13F shares	Current	Prev Q	Change
Total value	0.00	230.28 mm	EXIT
Total shares	0.00	17.26 mm	EXIT
Total puts	400.00	400.00	–
Total calls	12.00 k	2.20 k	+445.5%
Total put/call ratio	0.0	0.2	-81.7%

Largest owners	Shares	Value	Change
Simplex Trading	0.00	$0.00
Remeditex Ventures	0.00	$0.00	EXIT

Largest transactions	Shares	Bought/sold	Change
Remeditex Ventures	0.00	-9.64 mm	EXIT
Sio Capital Management	0.00	-824.80 k	EXIT
BLK BlackRock	0.00	-731.48 k	EXIT
Vanguard	0.00	-619.76 k	EXIT
Polar Asset Management Partners	0.00	-568.31 k	EXIT
Millennium Management	0.00	-493.60 k	EXIT
Vivaldi Asset Management	0.00	-373.00 k	EXIT
Alpine Associates Management	0.00	-316.10 k	EXIT
Candriam Luxembourg S.C.A.	0.00	-239.09 k	EXIT
MS Morgan Stanley	0.00	-231.38 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.